Clonal Blood Disorders

Trial Overview

Clonal Blood Cell Disorders. To elucidate the molecular mechanisms that cause blood cancers. We hope to understand aspects of normal and leukaemic stem cell biology that affect the clinical outcome for patients suffering from blood cell cancers. Blood cell disorders include: leukaemia, myeloproliferative disorders (MPD), myeloma and lymphoma.

Inclusion criteria

Patients will be invited by their haematology consultants to donate surplus samples of blood bone marrow, blood or other tissue obtained as part of their standard clinical care for this research project. In addition buccal smears and hair samples will be requested. The blood, bone marrow and other tissue samples will be processed so that blood cells, nucleic acids (DNA & RNA) and protein can be extracted.

Principal Investigator

Prof. David Bowen

Tel: 0113 2068481

E-mail: david.bowen@leedsth.nhs.uk

Research Nurse

Catherine Levy

Tel: 0113 2068577

E-mail: catherine.levy@leedsth.nhs.uk

Other trials currently active for Clonal Haematological Disorders

warning icon

Sorry, there are currently no other active trials

However, these pages are regularly updated with new trials so please check back again soon when new trials may be available.